Literature DB >> 17949350

Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.

Yoichi Kobayashi1, Yasuna Wada, Tatsuru Ohara, Yoshiko Okuda, Nao Suzuki, Kiyoshi Hasegawa, Kazushige Kiguchi, Bunpei Ishizuka.   

Abstract

In this study, the preliminary analyses were conducted of enzymatic activities of uridine phosphorylase (UP) and thymidine phosphorylase (TP) in normal tissues and cancer tissues of the uterine cervix. The study was performed on 27 patients of cervical cancer, treated first in our hospital. Normal cervical tissues obtained from 15 patients undergoing hysterectomy for benign diseases were used as controls. The supernatant of the homogenated cervical tissues and the stroma (5-FU and ribose-1-P or deoxyribose-1-P) were analyzed by high performance liquid chromatography, and then the UP and TP activities calculated. TP activity was significantly greater than UP activity (P < 0.0001). Both UP and TP showed significantly greater activity in cancer tissues than in normal tissues (P < 0.0001). In the TP activity of the cancer tissues, there was no significant difference among the histological types, while the TP activity tended to be significantly higher in the cases with lymph node metastasis. These results showed that the TP-mediated route seemed important as the 5FU metabolic pathway in the uterine cervical tissues, and TP enzymatic activity might be associated with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949350     DOI: 10.1111/j.1749-0774.2007.00036.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  16 in total

1.  Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells.

Authors:  M Ueda; Y Terai; K Kumagai; K Ueki; M Kanemura; M Ueki
Journal:  Int J Cancer       Date:  2001-03-15       Impact factor: 7.396

2.  Angiogenic activity of enzymes.

Authors:  M Haraguchi; K Miyadera; K Uemura; T Sumizawa; T Furukawa; K Yamada; S Akiyama; Y Yamada
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

3.  A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.

Authors:  N Petrelli; L Herrera; Y Rustum; P Burke; P Creaven; J Stulc; L J Emrich; A Mittelman
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

4.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

5.  Different angiogenic pathways in human cervical cancers.

Authors:  K Tokumo; J Kodama; N Seki; Y Nakanishi; Y Miyagi; S Kamimura; M Yoshinouchi; H Okuda; T Kudo
Journal:  Gynecol Oncol       Date:  1998-01       Impact factor: 5.482

6.  Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.

Authors:  S Sato; A Yajima; H Sasaki; K Mizutani; H Honjo; K Yamamoto; M Ozaki; K Hasegawa; T Kudo; M Yakushiji; M Hatae; K Noda
Journal:  Oncol Rep       Date:  2001 Mar-Apr       Impact factor: 3.906

7.  Thymidine phosphorylase expression in tumor stroma of uterine cervical carcinomas: histological features and microvessel density.

Authors:  W Tang; X Wang; H Utsunomiya; Y Nakamuta; Q Yang; Q Zhang; G Zhou; Y Tsubota; Y Mabuchi; L Li; K Kakudo
Journal:  Cancer Lett       Date:  2000-02-01       Impact factor: 8.679

8.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

Review 9.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

10.  Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

Authors:  M Ueda; K Kitaura; O Kusada; Y Mochizuki; N Yamada; Y Terai; K Kumagai; K Ueki; M Ueki
Journal:  Jpn J Cancer Res       Date:  2000-11
View more
  3 in total

1.  Relative mRNA expression of prostate-derived E-twenty-six factor and E-twenty-six variant 4 transcription factors, and of uridine phosphorylase-1 and thymidine phosphorylase enzymes, in benign and malignant prostatic tissue.

Authors:  Luciane Rostirola Cavazzola; Gustavo Franco Carvalhal; Candida Deves; Daiana Renck; Ricardo Almeida; DIóGENES Santiago Santos
Journal:  Oncol Lett       Date:  2015-04-01       Impact factor: 2.967

2.  Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.

Authors:  Z Q Yuan; L Nicolson; B Marchetti; E A Gault; M S Campo; L Nasir
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

Review 3.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.